NeuroPace Statistics
Share Statistics
NeuroPace has 32.75M
shares outstanding. The number of shares has increased by 13.18%
in one year.
| Shares Outstanding | 32.75M |
| Shares Change (YoY) | 13.18% |
| Shares Change (QoQ) | 9.09% |
| Owned by Institutions (%) | 70.87% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 5,420 |
| FTD / Avg. Volume | 2.33% |
Short Selling Information
The latest short interest is 393.66K, so 1.2% of the outstanding
shares have been sold short.
| Short Interest | 393.66K |
| Short % of Shares Out | 1.2% |
| Short % of Float | 2.04% |
| Short Ratio (days to cover) | 3.13 |
Valuation Ratios
The PE ratio is -12.01 and the forward
PE ratio is -21.93.
NeuroPace's PEG ratio is
0.45.
| PE Ratio | -12.01 |
| Forward PE | -21.93 |
| PS Ratio | 4.08 |
| Forward PS | 1.8 |
| PB Ratio | 40.67 |
| P/FCF Ratio | -17.85 |
| PEG Ratio | 0.45 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for NeuroPace.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.37,
with a Debt / Equity ratio of 9.15.
| Current Ratio | 5.37 |
| Quick Ratio | 4.48 |
| Debt / Equity | 9.15 |
| Debt / EBITDA | -4.42 |
| Debt / FCF | -4.02 |
| Interest Coverage | -2.46 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $434,271.74 |
| Profits Per Employee | $-147,505.43 |
| Employee Count | 184 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 1.56 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 51.82% in the
last 52 weeks. The beta is 2.05, so NeuroPace's
price volatility has been higher than the market average.
| Beta | 2.05 |
| 52-Week Price Change | 51.82% |
| 50-Day Moving Average | 11.62 |
| 200-Day Moving Average | 9.96 |
| Relative Strength Index (RSI) | 60.83 |
| Average Volume (20 Days) | 232,596 |
Income Statement
In the last 12 months, NeuroPace had revenue of 79.91M
and earned -27.14M
in profits. Earnings per share was -0.93.
| Revenue | 79.91M |
| Gross Profit | 59.09M |
| Operating Income | -21.67M |
| Net Income | -27.14M |
| EBITDA | -16.57M |
| EBIT | -18.34M |
| Earnings Per Share (EPS) | -0.93 |
Full Income StatementBalance Sheet
The company has 13.43M in cash and 73.34M in
debt, giving a net cash position of -59.91M.
| Cash & Cash Equivalents | 13.43M |
| Total Debt | 73.34M |
| Net Cash | -59.91M |
| Retained Earnings | -530.95M |
| Total Assets | 94.65M |
| Working Capital | 66.18M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -17.95M
and capital expenditures 0, giving a free cash flow of -18.25M.
| Operating Cash Flow | -17.95M |
| Capital Expenditures | n/a |
| Free Cash Flow | -18.25M |
| FCF Per Share | -0.63 |
Full Cash Flow StatementMargins
Gross margin is 73.94%, with operating and profit margins of -27.12% and -33.97%.
| Gross Margin | 73.94% |
| Operating Margin | -27.12% |
| Pretax Margin | -33.97% |
| Profit Margin | -33.97% |
| EBITDA Margin | -20.74% |
| EBIT Margin | -27.12% |
| FCF Margin | -22.85% |
